PVH
6.10.2020 18:02:13 CEST | Business Wire | Press release
PVH Europe, the global headquarters of Tommy Hilfiger and the European offices of Calvin Klein, both owned by PVH Corp. [NYSE: PVH], announces the installation of what is believed to be the world’s most powerful* currently operational solar roof at its state-of-the-art Warehouse and Logistics Center in Venlo, the Netherlands. Generated by more than 48,000 solar panels, the solar roof covers the Center’s electricity footprint, as well as indirectly providing 100% of all energy for PVH Europe’s warehouses, offices and stores in the Netherlands via the Dutch public power network. PVH Europe’s energy partner, Eneco, has certified that all energy needed to power these buildings is generated by the new rooftop installation. The Venlo Warehouse and Logistics Center is owned by Heylen Warehouses, a Belgian logistics real estate company, in a joint venture with AG Real Estate, and retained IZEN as the technical installation partner for the roof.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201006005513/en/
This milestone marks another step in PVH’s journey to procure 100% of its electricity from renewable sources for its offices, warehouses and stores, and to drive a 30% reduction in supply chain carbon emissions by 2030. This work is linked to PVH’s science-based emissions target aligned with the most ambitious level of decarbonization as set out by the Paris Agreement. It is also one of the priorities outlined in the company’s Forward Fashion corporate responsibility strategy, which aims to reduce negative impacts to zero, increase positive impacts to 100% and improve the over 1 million lives across the company’s value chain.
Key Facts:
- The Venlo warehouse is PVH Europe’s main distribution center covering 110,000m2 .
- Awarded a BREEAM (Building Research Establishment Environmental Assessment Method) sustainability rating of “Very Good”.
- The world’s most powerful solar roof, with a capacity to generate 18 MWp (megawatt peak).
- Facilitated by over 48,000 high performance solar panels.
- Fully powers all PVH Europe owned stores, warehouses and offices in the Netherlands.
“This is an incredible milestone for our Warehouse and Logistics Center in Venlo and for PVH Europe’s sustainability journey,” said Martijn Hagman, CEO ,Tommy Hilfiger Global and PVH Europe. “We have participated in the installation of what we believe is now the world’s most powerful, fully operational solar roof – a huge stride in our commitment to be powered by 100% renewable electricity by 2030 and reduce supply chain emissions by 30% by 2030. This would not have been possible without a best-in-class team of such talented, passionate, and devoted PVH associates.”
At present, up to 600,000 pieces of TOMMY HILFIGER and CALVIN KLEIN product are distributed daily from the PVH Europe Warehouse and Logistics Center in Venlo to points of sale, including owned and operated stores in Europe, the Middle East and Africa, and direct to customers. The warehouse’s Very Good rating by BREEAM incorporates exemplary standards for energy, water, transport, materials, waste, pollution, ecology, health and well-being. This is reflected through energy efficient lighting in 100% of the space, the use of 100% FSC (Forest Stewardship Council) certified packaging and 100% recycling of all cardboard, plastics and printed material.
PVH is a member of RE100, the corporate renewable electricity initiative led by the Climate Group, and has committed to RE100 to procure 100% of its electricity from renewable sources by 2030.
Sam Kimmins, Head of RE100 at the Climate Group said: “Congratulations to PVH on the finalization of the Venlo solar rooftop. This is another exciting step in their global work and partnership towards their 2025 RE100 target. It raises the bar once more for on-site renewables.”
“ We believe that logistic buildings will be the next generation of solar power plants,” said Philippe Deschilder, CEO of Heylen Warehouses. “The partnership with PVH Europe for the solar roof project supports our ambition to invest in renewable energy, creating added value for our customers by enabling them to reduce their carbon footprint.”
About PVH Corp.
PVH is one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our brand portfolio includes the iconic CALVIN KLEIN , TOMMY HILFIGER , Van Heusen , IZOD , ARROW, Warner’s , Olga and Geoffrey Beene brands, as well as the digital-centric True&Co. intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 40,000 associates operating in over 40 countries and $9.9 billion in annual revenues. That's the Power of Us. That’s the Power of PVH.
Follow us on Facebook , Instagram , Twitter and LinkedIn .
About RE100
RE100 is a global initiative bringing together the world’s most influential businesses committed to 100% renewable power. Led by the Climate Group in partnership with CDP , the group has a total revenue of over US$5.4 trillion and operates in a diverse range of sectors. Together, they send a powerful signal to policymakers and investors to accelerate the transition to a clean economy. #RE100
*PVH defines the “world’s most powerful solar roof” as the most powerful solar roof that is currently operational and installed on one singular structure.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201006005513/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom